The displays highlighted natural planning, like moss paving and gravel paths bleeding into greenery. One garden was an example of the Atlantic temperate rainforest habitat that once covered western coasts of Britain.
, an outspoken critic of the FDA’s handling ofMakary and other Trump administration officials already have taken unprecedented steps that raise uncertainty about next fall’s COVID-19 vaccinations, including delaying FDA scientists’
— and then restricting its use to people at higher risk from the virus. They’ve also suggestedto match the latest circulating virus strains are new products requiring extra testing.The changes cross multiple health agencies.
The Centers for Disease Control and Prevention hasn’t yet acted onon use of a new meningitis shot or broader RSV vaccination. A meeting of
allies was recently told to expect an end to COVID-19 booster recommendations for children — something that vaccine advisory panel was supposed to debate in June. And researchers around the country lost National Institutes of Health funding to study vaccine hesitancy.
“I think you have to assume that RFK Jr.’s intention is to make it harder for vaccines to come to market,” said Dr. Amesh Adalja, a vaccine expert at Johns Hopkins University. The changes are “looked at suspiciously because this is someone with a proven track record of evading the value of vaccines.”that has whipsawed Nvidia and other Big Tech companies riding AI mania to propel their revenue and stock prices upward.
But Trump’s tariffs — many of which have been reduced or temporarily suspended – hammered the market values of Nvidia and other tech powerhousesas investors fretted about the trade turmoil dimming the industry’s prospects.
Those worries have eased during the past six weeks as most Big Tech companies lived up to or exceeded the analyst projections that steer investors, capped by Nvidia’s report for its fiscal first quarter.AP business correspondent Seth Sutel reports on Wall Street.